Home > Products > Human Tumor Cell Lines >
MCAS | ||||
---|---|---|---|---|
Product Name | MCAS | |||
Price | Get Quote | |||
Cat.No | ABL-TC0396 | Species | Human | |
Size/Quantity | 1 vial | Biosafety Level | 1 | |
Shipping Info | Dry Ice | Storage | Liquid Nitrogen | |
Description | The MCAS cell line was derived from mucinous cystadenocarcinoma of the ovary and has a doubling time of 27 hours, according to the original published paper. In culture, these cells form a monolayer with a pavement-like cellular arrangement. They exhibit rather large cells with vacuoles in the cytoplasm when confluent, and PAS staining shows positivity specifically in these large cells. Chromosomal analysis indicates a peritetraploid tendency. When heterotransplanted into nude athymic mice, MCAS cells develop tumors with both cystic and solid components, making them a valuable tool for ovarian cancer research.
Why choose MCAS from AcceGen? The MCAS cell line from AcceGen offers superior quality and viability, maintained under sterile conditions, and certified negative for bacteria, fungi, and mycoplasma. To ensure safety, PCR assays confirm the absence of human pathogens. Identity is verified through STR analysis, making it a reliable resource for research applications. | |||
Source Organ | Ovary | |||
Recommended Medium And Supplement | EMEM + 20% FBS | |||
Citation Guide | When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID). | |||
Application | FOR RESEARCH USE ONLY The MCAS cell line is a crucial asset in the field of human ovarian carcinoma research, particularly for investigating potential treatments and underlying mechanisms for inhibiting the growth of mucinous ovarian carcinoma tumor cells. Researchers employ MCAS cells to identify drugs and study their effects, shedding light on promising molecular therapies. This cell line serves as a valuable tool to explore novel therapeutic strategies and develop a deeper understanding of mucinous ovarian carcinoma, ultimately contributing to advancements in cancer treatment. | |||
Growth Conditions | 37 ℃, 5% CO2 | |||
Product Type | Human Ovarian Cancer Cell Lines | |||
Product Image |
- ONLINE INQUIRY
- PRODUCT REVIEWS
Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.